Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
---|
07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
07/05/2007 | US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence |
07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
07/05/2007 | US20070155657 Hypoglycemic agent |
07/05/2007 | US20070155656 Hypoglycemic agent |
07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
07/05/2007 | US20070154574 Fungicides compositions comprising the extract of Chloranthus henryi and a novel sesquiterpene compound isolated from them |
07/05/2007 | CA2633525A1 3'-alkoxy-spirocyclopentyl-substituted tetramic and tetronic acids |
07/05/2007 | CA2630478A1 Processes for preparing darifenacin hydrobromide |
07/05/2007 | CA2626715A1 Processes for preparing darifenacin hydrobromide |
07/05/2007 | CA2625858A1 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof |
07/04/2007 | EP1802598A2 Asymmetric synthesis of dihydrobenzofuran derivatives |
07/04/2007 | EP1802597A1 Asymmetric synthesis of substituted dihydrobenzofurans |
07/04/2007 | EP1802583A1 Heterocyclic carbonyl compounds |
07/04/2007 | EP1263735B1 Acid addition salts of imidazolidinones as reaction catalysts |
07/04/2007 | CN1993366A Synthesis of aldonolactones, aldarolactones, and aldarodilactones using gas sparging |
07/04/2007 | CN1993365A Synthesis of aldonolactones, aldarolactones, and aldarodilactones using azeotrophic distillation |
07/04/2007 | CN1993343A Tetracyclic compounds as estrogen ligands |
07/04/2007 | CN1993342A Intermediates for the preparation of halichondrin b |
07/04/2007 | CN1993321A 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
07/04/2007 | CN1990477A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
07/04/2007 | CN1990476A Method for preparing furfuryl alcohol by furfural selective hydrogenation reaction in liquid phase |
07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
07/04/2007 | CN1324259C Pipe joint assembly and method for using same |
07/04/2007 | CN1324008C Novel compounds and compositions as cathepsin inhibitors |
07/04/2007 | CN1324006C Beta-amino acid nitrile derivs. |
07/04/2007 | CN1323666C Stabilized aqueuos folic acid preparation and its production |
07/04/2007 | CN1323654C Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
07/03/2007 | US7240033 Information providing apparatus and method, information processing apparatus and method, program storage medium, program, and information providing system |
07/03/2007 | US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
07/03/2007 | CA2252465C Urea derivatives as inhibitors of impdh enzyme |
07/03/2007 | CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds |
06/28/2007 | WO2007072782A1 Carboxylic acid derivative or salt thereof |
06/28/2007 | WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives |
06/28/2007 | WO2007071766A2 Phenoxy acetic acids as ppar delta activators |
06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
06/28/2007 | WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
06/28/2007 | US20070149615 Ketone compounds and compositions for cholesterol management and related uses |
06/28/2007 | US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay |
06/28/2007 | US20070149558 Benzo-fused 5-membered heterocyclic compounds, their production and use |
06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
06/28/2007 | US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay |
06/28/2007 | DE102005059891A1 3'-Alkoxy-spirocyclopentyl substituierte Tetram- und Tetronsäuren 3-alkoxy-substituted tetramic spirocyclopentyl and tetronic acids |
06/28/2007 | CA2631390A1 Phenoxy acetic acids as ppar delta activators |
06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
06/27/2007 | EP1801105A1 Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions |
06/27/2007 | EP1801104A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
06/27/2007 | EP1801087A1 Cis-1,2-substituted stilbene derivates and the use thererof for manufacturing medicaments for treating medicaments for treating and/or preventing diabetes |
06/27/2007 | EP1799808A1 Process for producing mycophenolic acid using penicillium arenicola bicc7673 |
06/27/2007 | EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases |
06/27/2007 | EP1799632A2 Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide |
06/27/2007 | EP1483238B1 Method for the simultaneous production of tetrahydrofurans and pyrrolidones |
06/27/2007 | EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides |
06/27/2007 | CN1989122A Novel cylopenta[b]benzofuran derivatives and the utilization thereof |
06/27/2007 | CN1989121A Process for the preparation of optically-active compounds |
06/27/2007 | CN1989117A Substituted benzothiazoles |
06/27/2007 | CN1989100A Therapeutic compounds |
06/27/2007 | CN1989099A Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
06/27/2007 | CN1986543A Cancer chemotherapy |
06/27/2007 | CN1986538A Preparing process of 5-alkyl-2-(5H)-ketofuran |
06/27/2007 | CN1986537A Azeotropic distillation and multiple stage of countercurrent liquid-liquid extraction process for concentrating furaldehyde |
06/26/2007 | US7236201 Method of generating an image in a turbid medium |
06/26/2007 | US7235690 Anthranilamides and methods of their use |
06/26/2007 | US7235675 Conjugates of mycophenolic acid |
06/26/2007 | US7235667 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
06/26/2007 | US7235568 N-dihydrobenzofuran-7-yloxyethyl-substituted, e.g., [2-(2,2-Dimethyl-2,3-dihydrobenzofuran-7-yl-oxy)ethyl]-(5-cyclopenten-1-ylpyridin-3-ylmethyl)amine; benzofuran ring may 2-spirocyclopropyl- or 2-spirocyclobutyl-substituted |
06/21/2007 | WO2007069838A1 A manufacturing process of 2',2'-difluoronucleoside and intermediate |
06/21/2007 | WO2007069569A1 Organic electroluminescence element material and organic electroluminescence element using same |
06/21/2007 | WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders |
06/21/2007 | WO2006124861A3 Benzofuran compounds |
06/21/2007 | WO2005037223A3 Methods and compositions for immunomodulation |
06/21/2007 | US20070142679 Hydrogenation of dicarboxylic acids to form diols, cyclic ethers and lactones in the presence of an aqueous solution of a ruthenium, rhodium, iron, osmium or palladium compound and a phosphine, preferably tridentate facially capped phosphines (tris-1,1,1-(diarylphosphinomethyl)alkane) |
06/21/2007 | US20070142648 Hydrogenation method for producing optically active alcohols or carboxylic acids |
06/21/2007 | US20070142639 Process for production of amines |
06/21/2007 | US20070142638 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
06/21/2007 | US20070142633 Process for converting carbohydrates to hydrocarbons |
06/21/2007 | US20070142631 Enzyme inhibiton immunoassay |
06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
06/21/2007 | US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives |
06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
06/21/2007 | US20070142381 Calcium receptor modulating agents |
06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
06/21/2007 | US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay |
06/21/2007 | US20070140998 Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer |
06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
06/21/2007 | CA2631951A1 A manufacturing process of 2',2'-difluoronucleoside and intermediate |
06/21/2007 | CA2604928A1 Methods for obtaining optically active epoxides and diols from 2,3-disubstituted and 2,3-trisubstituted epoxides |
06/21/2007 | CA2571640A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
06/21/2007 | CA2570680A1 Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions |
06/20/2007 | EP1797100A1 Nitrate esters and their use for mitigating cellular damage |
06/20/2007 | EP1797065A2 Acyclic 1,3-diamines and uses therefor |
06/20/2007 | EP1797064A1 Novel compounds useful for modulating abnormal cell proliferation |
06/20/2007 | EP1797062A1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors |
06/20/2007 | EP1797061A1 Method for the distillative processing of tetrahydrofuran |
06/20/2007 | EP1797060A2 "process for preparation of citalopram and enantiomers" |
06/20/2007 | EP1797052A1 Bicyclic compounds which inhibit beta-secretase activity and methods of use thereof |